Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Heart Attack Risk Determined by Specific Genes

By LabMedica International staff writers
Posted on 17 Feb 2009
The genetic risk of suffering a heart attack, regardless of a person's ethnic background, might be predicted by a simple blood test. More...


A group of Canadian and British investigators pinpointed specific genes and their association with an increased risk of heart attack. They extracted DNA from 8,795 individuals of European, south Asian, Arab, Iranian, and Nepalese origin and genotyped 1,536 single nucleotide polymorphisms (SNPs) from 103 genes. SNPs are single base pair variations in DNA, which occur within genes and, in some cases, change the production of proteins or alter the expression of other genes.

The results of the study showed a significant association between four genes, and high cholesterol levels, particularly ApolipoproteinB (ApoB)/A1 levels, which is the primary protein involved in "bad cholesterol" and responsible for carrying cholesterol to tissues. The scientists concluded that 13 common SNPs were associated with heart disease risk factors and one variant was independently associated with the risk of a heart attack.

"Most genetic studies have focused on studying white Caucasians," said Professor Sonia Anand, director of the Population Genomics Program at McMaster University (Hamilton, ON, Canada). "The unique contribution of our study is that we demonstrate that common genetic variants are indeed common across five ethnic groups. Furthermore, we are able to put the contribution of these factors on the risk of heart attack into perspective, demonstrating that the nine risk factors account for the vast majority of heart attacks and the genetic variants while important only add a small independent contribution to the risk of heart attack."

An earlier study led by Professor Salim Yusuf at McMaster University showed that nine risk factors accounted for more than 90% of the risk for heart attacks globally. Those nine risk factors are dyslipidemia/high cholesterol, diabetes, hypertension, abdominal obesity, tobacco, physical inactivity, psychosocial stressors, low fruit and vegetable intake, and no alcohol consumption. Together with the genetic variants (SNPs), the prediction of risk of myocardial infarction (MI) was increased by 1.6%.

Scientists believe that common SNPs may be associated with the development of a number of chronic diseases such as cancer, diabetes, vascular disease, and some forms of mental illness.

Related Links:

McMaster University



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.